KingCreate Biotechnology
Latest round
- Series C
Last raised
- Aug 2023
Total raised
- $15M
Investors
- 6
About KingCreate Biotechnology
Established in 2016 and based in Guangzhou, China, Yunjing operates as a biotechnology company that provides precision medical in vitro diagnostic products. The company cooperates with illumina, Nayo Lab and Henan Cancer Hospital, etc. It covers an area of about 3300 square feet and has over 2500 square feet of instrument production workshop, reagent production workshop, QC production workshop, testing laboratory and R&D laboratory. In April 2020, the company promoted the Desktop High-Throughput Sequencer with Illumina. In October 2021, it was awarded the title of "2021 Guangzhou Future Unicorn Innovative Enterprise". The company provides tNGS (targeted sequencing) technology platforms and molecular diagnostics solutions. Its product mainly includes medical devices, including KM MiniSeqDx-CN, liquid-based cell and lung cancer kit. And it has many clinical trial products, such as lung cancer rayon 11 gene organized version and colorectal cancer raytek 10 gene tissue version.
Who invested in KingCreate Biotechnology
6 investors across 3 rounds
See all investors in KingCreate Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about KingCreate Biotechnology
Who invested in KingCreate Biotechnology?
KingCreate Biotechnology has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has KingCreate Biotechnology raised?
KingCreate Biotechnology has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did KingCreate Biotechnology last raise money?
KingCreate Biotechnology's most recent round on record is a Series C, in Aug 2023.
What does KingCreate Biotechnology do?
Established in 2016 and based in Guangzhou, China, Yunjing operates as a biotechnology company that provides precision medical in vitro diagnostic products.
Where is KingCreate Biotechnology headquartered?
KingCreate Biotechnology is headquartered in Guangzhou, China.
Which VCs invest in companies like KingCreate Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at KingCreate Biotechnology's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like KingCreate Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.